Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thyroglobulin proteolysis refers to the enzymatic breakdown of thyroglobulin (Tg) within thyroid follicular cells. This process is essential for the synthesis and release of thyroid hormones thyroxine (T4) and triiodothyronine (T3). It involves the action of lysosomal cathepsins (B, D, L, and K) that cleave Tg at specific sites, liberating T3 and T4 into circulation. Dysregulation can lead to various thyroid disorders, including hypothyroidism, goiter, and autoimmune thyroid diseases.
N/A - This is a process, not a target for direct drug intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thyroglobulin Proteolysis (Tg Proteolysis).